- Rocket Pharmaceuticals Presents Positive Data from LV Hematology Portfolio at the 27th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)
- Rocket Pharmaceuticals Reports First Quarter 2024 Financial Results and Highlights Recent Progress
- Rocket Pharmaceuticals Announces European Medicines Agency Acceptance of RP-L102 Marketing Authorization Application for the Treatment of Fanconi Anemia
- Rocket Pharmaceuticals Announces Appointment of Aaron Ondrey as Chief Financial Officer and Additional Updates to Corporate Leadership Team
- Rocket Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Progress
More ▼
Key statistics
On Friday, Rocket Pharmaceuticals Inc (RCKT:NMQ) closed at 22.62, 51.91% above the 52 week low of 14.89 set on Aug 21, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 23.46 |
---|---|
High | 23.56 |
Low | 22.45 |
Bid | 22.40 |
Offer | 24.50 |
Previous close | 23.40 |
Average volume | 491.78k |
---|---|
Shares outstanding | 90.78m |
Free float | 85.87m |
P/E (TTM) | -- |
Market cap | 2.05bn USD |
EPS (TTM) | -2.87 USD |
Data delayed at least 15 minutes, as of May 17 2024 21:00 BST.
More ▼